The current price of 2269.HK is HK$48.68 — it has increased by 0.75% since the previous close. Data as of Nov 5, 2026.
2269.HK is up 7.04% over the past week, down 12.13% over the past month and up 39.24% over the past year. The price is above its 200-day moving average of HK$40.00.
Of the 27 analysts covering WuXi Biologics (Cayman) Inc., 5 rate it a strong buy, 18 rate it a buy and 4 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
WuXi Biologics (Cayman) Inc. has a market capitalization of HK$200.38B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In the latest trading session 2269.HK moved between HK$48.24 and HK$55.55, a range of 15.02% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of WuXi Biologics (Cayman) Inc. shows a buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for WuXi Biologics (Cayman) Inc. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks 2269.HK has traded between HK$28.48 and HK$58.00. The current price is 16.07% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.